The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

The FDA declared a shortage of popular weight-loss and diabetes drugs. Here's what that means for people who get generic ...

Eli Lilly and Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...